FDAnews Drug Daily Bulletin

ANADYS PHARMACEUTICALS REPORTS THIRD QUARTER 2005 FINANCIAL RESULTS

Nov. 3, 2005
A A

Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS), a biopharmaceutical company committed to the discovery, development and commercialization of novel anti-infective medicines, today reported its operational highlights and financial results for the quarter ended September 30, 2005. "We are very proud of what we accomplished in the past quarter," said Kleanthis G. Xanthopoulos, Ph.D., Anadys' President and Chief Executive Officer.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/11-01-2005/0004205815&EDATE)